It is crucial to weigh the potential advantages against the risks, especially for patients with a predisposition to colorectal cancer. Ongoing research aims to clarify the relationship between GLP-1 receptor agonists and colorectal cancer
These developments mark important milestones in the ongoing research and development of the oral GLP1R agonist
The dose-dependent nature of semaglutide-associated nodules, documented in the first published case report, suggests that dose reduction may resolve the problem when nodules occur repeatedly
The catalytic tetrad formed by Sec, glutamine, tryptophan and asparagine is essential for GPx activity, since these residues are crucial for enzyme-substrate interaction and stabilization of the GSH-GPx interaction [47, 65, 66]
Doctors may prescribe it for adults with obesity (a BMI of 30 or higher) or those who are overweight (a BMI of 27 or higher) and have other medical conditions such as diabetes, hypertension, and hypercholesterolemia
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial